|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Cyteir Therapeutics, Inc.
| | | Phone: | (857) 285-4140 | Year Established: | 2012 | Main Contact: | Markus Renschler, MD, President & CEO | | Other Contacts: | Joseph Vacca, PhD, Head of Chemistry Ronald Goldstein, CPA, CFO Darryl Patrick, PhD, DVM, Head of Preclinical R&D Kevin Mills, PhD, Founder & CSO
| | Company Description | Cyteir Therapeutics is a leader in the discovery and development of novel therapeutics based on the biology of DNA repair and synthetic lethality for the treatment of cancer and autoimmune diseases. The company’s initial approach takes advantage of the “gain-of-function” from DNA damage overload to induce selective self-destruction of cells by targeting disease-induced RAD51 transport. | |
|
|
|
|
|